Literature DB >> 24758945

Managing ADHD and disruptive behaviour disorders with combination psychostimulant and antipsychotic treatment.

Dean Elbe1, Alasdair M Barr2, William G Honer3, Ric M Procyshyn3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24758945      PMCID： PMC3997610          DOI： 10.1503/jpn.130288

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  10 in total

1.  Ten years of antipsychotic prescribing to children: a Canadian population-based study.

Authors:  Silvia Alessi-Severini; Robert G Biscontri; David M Collins; Jitender Sareen; Murray W Enns
Journal:  Can J Psychiatry       Date:  2012-01       Impact factor: 4.356

2.  The dopamine dilemma: using stimulants and antipsychotics concurrently.

Authors:  Jason Yanofski
Journal:  Psychiatry (Edgmont)       Date:  2010-06

3.  The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder.

Authors:  Steven R Pliszka; M Lynn Crismon; Carroll W Hughes; C Keith Corners; Graham J Emslie; Peter S Jensen; James T McCRACKEN; James M Swanson; Molly Lopez
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2006-06       Impact factor: 8.829

4.  Lack of effect of stimulant combination with second-generation antipsychotics on weight gain, metabolic changes, prolactin levels, and sedation in youth with clinically relevant aggression or oppositionality.

Authors:  Julie B Penzner; Melissa Dudas; Ema Saito; Vladimir Olshanskiy; Umesh H Parikh; Sandeep Kapoor; Raja Chekuri; Dominick Gadaleta; Jennifer Avedon; Eva M Sheridan; Jane Randell; Anil K Malhotra; John M Kane; Christoph U Correll
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-10       Impact factor: 2.576

5.  Evidence-based recommendations for monitoring safety of second generation antipsychotics in children and youth.

Authors:  Tamara Pringsheim; Constadina Panagiotopoulos; Jana Davidson; Josephine Ho
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2011-08

Review 6.  Antipsychotic and psychostimulant drug combination therapy in attention deficit/hyperactivity and disruptive behavior disorders: a systematic review of efficacy and tolerability.

Authors:  David Linton; Alasdair M Barr; William G Honer; Ric M Procyshyn
Journal:  Curr Psychiatry Rep       Date:  2013-05       Impact factor: 5.285

Review 7.  International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions.

Authors:  Stan Kutcher; Michael Aman; Sarah J Brooks; Jan Buitelaar; Emma van Daalen; Jörg Fegert; Robert L Findling; Sandra Fisman; Laurence L Greenhill; Michael Huss; Vivek Kusumakar; Daniel Pine; Eric Taylor; Sam Tyano
Journal:  Eur Neuropsychopharmacol       Date:  2004-01       Impact factor: 4.600

8.  A naturalistic study of predictors and risks of atypical antipsychotic use in an attention-deficit/hyperactivity disorder clinic.

Authors:  Margaret Weiss; Constadina Panagiotopoulos; Lauren Giles; Christopher Gibbins; Boris Kuzeljevic; Jana Davidson; Rebecca Harrison
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-10       Impact factor: 2.576

Review 9.  Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II.

Authors:  Elizabeth Pappadopulos; James C Macintyre Ii; M Lynn Crismon; Robert L Findling; Richard P Malone; Albert Derivan; Nina Schooler; Lin Sikich; Laurence Greenhill; Sarah B Schur; Chip J Felton; Harvey Kranzler; David M Rube; Jeffrey Sverd; Molly Finnerty; Scott Ketner; Sonja E Siennick; Peter S Jensen
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2003-02       Impact factor: 8.829

10.  Prevalence and patterns of antipsychotic use in youth at the time of admission and discharge from an inpatient psychiatric facility.

Authors:  Ric M Procyshyn; Johnny Su; Dean Elbe; Angela Y Liu; William J Panenka; Jana Davidson; William G Honer; Alasdair M Barr
Journal:  J Clin Psychopharmacol       Date:  2014-02       Impact factor: 3.153
  10 in total
  3 in total

1.  Low-dose quetiapine complements stimulant response in attention deficit hyperactivity disorder and more.

Authors:  Ahmed Naguy
Journal:  Ther Adv Psychopharmacol       Date:  2016-10-13

Review 2.  Long-acting injectable antipsychotics for early psychosis: A comprehensive systematic review.

Authors:  Lulu Lian; David D Kim; Ric M Procyshyn; Diana Cázares; William G Honer; Alasdair M Barr
Journal:  PLoS One       Date:  2022-04-29       Impact factor: 3.240

3.  In vitro pharmacological characterization of SPN-810M (molindone).

Authors:  Chungping Yu; Gopakumar Gopalakrishnan
Journal:  J Exp Pharmacol       Date:  2018-11-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.